Phase 2b Study Evaluates Glecirasib in Certain Patients With KRAS-Positive NSCLC
Does Adjuvant Therapy Benefit High-Risk Liver Cancer Patients? Insights from IMbrave050
Gemcitabine and Cisplatin +/- Nab-Paclitaxel for Newly Diagnosed BTC: Results From SWOG S1815